Identification of IFN-α-producing innate B cells

Cell Research

Volumn 24, Issue 2, 2014, Pages 161-176

  Bao, Yan ^a,b   Liu, Xingguang ^b   Han, Chaofeng ^b   Xu, Sheng ^b   Xie, Bin ^b   Zhang, Qian ^b   Gu, Yan ^b   Hou, Jin ^b   Qian, Li ^b   Qian, Cheng ^b   Han, Huanxing ^a   Cao, Xuetao ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

B cells; CD40; dendritic cells; IFN ; innate response

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LISTERIA MONOCYTOGENES; MUS; VESICULAR STOMATITIS VIRUS;

AGAMMAGLOBULINAEMIA TYROSINE KINASE; CD40 ANTIGEN; CD40 LIGAND; FC RECEPTOR; FCGR3 PROTEIN, MOUSE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEIN TYROSINE KINASE;

ANIMAL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DENDRITIC CELL; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; LISTERIA MONOCYTOGENES; METABOLISM; MOUSE; PATHOGENICITY;

ANIMALS; ANTIGENS, CD11A; ANTIGENS, CD40; B-LYMPHOCYTES; BONE MARROW CELLS; CD40 LIGAND; CELLS, CULTURED; DENDRITIC CELLS; IMMUNITY, INNATE; INTERFERON-GAMMA; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PROTEIN-TYROSINE KINASES; RECEPTORS, IGG;

EID: 84893813124     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.155     Document Type: Article

References (56)

1. Baumgarth N. The double life of a B-1 cell: Self-reactivity selects for protective effector functions. Nat Rev Immunol 2011; 11:34-46.
2. Lund FE, Randall TD. Effector and regulatory B cells: Modulators of CD4+ T cell immunity. Nat Rev Immunol 2010; 10:236-247.
3. Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008; 20:332-338.
4. Baumgarth N, Herman OC, Jager GC, et al. B-1 and B-2 cellderived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000; 192:271-280.
5. Mauri C, Ehrenstein MR. The short history of regulatory B cells. Trends Immunol 2008; 29:34-40.
6. Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol 2006; 176:705-710.
7. Pelletier N, McHeyzer-Williams LJ, Wong KA, et al. Plasma cells negatively regulate the follicular helper T cell program. Nat Immunol 2010; 11:1110-1118.
8. Wojciechowski W, Harris DP, Sprague F, et al. Cytokine-producing effector B cells regulate type immunity to H. polygyrus. Immunity 2009; 30:421-433.
9. Hao Y, ONeill P, Naradikian MS, et al. A B-cell subset uniquely responsive to innate stimuli accumulates in aged mice. Blood 2011; 118:1294-1304.
10. Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T celldependent inflammatory responses. Immunity 2008; 28:639-650.
11. Yang M, Sun L, Wang S, et al. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. J Immunol 2010; 184:3321-3325.
12. Horikawa M, Minard-Colin V, Matsushita T, et al. Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest 2011; 121:4268-4280.
13. Poe JC, Smith SH, Haas KM, et al. Amplified B lymphocyte CD40 signaling drives regulatory B10 cell expansion in mice. PLoS One 2011; 6:e22464.
14. Bermejo DA, Jackson SW, Gorosito-Serran M, et al. Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORt and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 2013; 14:514-522.
15. Tu W, Lau YL, Zheng J, et al. Efficient generation of human alloantigen-specific CD4+ regulatory T cells from naive precursors by CD40-activated B cells. Blood 2008; 112:2554-2562.
16. Jackaman C, Cornwall S, Graham PT, et al. CD40-activated B cells contribute to mesothelioma tumor regression. Immunol Cell Biol 2011; 89:255-267.
17. Sindhava VJ, Tuna H, Gachuki BW, et al. Bone marrow dendritic cell-mediated regulation of TLR and B cell receptor signaling in B cells. J Immunol 2012; 189:3355-3367.
18. Bossen C, Cachero TG, Tardivel A, et al. TACI, unlike BAFFR, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts. Blood 2008; 111:1004-1012.
19. Balázs M, Martin F, Zhou T, et al. Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 2002; 17:341-352.
20. Qian L, Qian C, Chen Y, et al. Regulatory dendritic cells program B cells to differentiate into CD19hiFcIIbhi regulatory B cells through IFN- and CD40L. Blood 2012; 120:581-591.
21. González-Navajas JM, Lee J, David M, et al. Immunomodulatory functions of type I interferons. Nat Rev Immunol 2012; 12:125-135.
22. MacMicking JD. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat Rev Immunol 2012; 12:367-382.
23. Yan N, Chen ZJ. Intrinsic antiviral immunity. Nat Immunol 2012; 13:214-222.
24. Bowie AG, Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008; 8:911-922.
25. Presti RM, Pollock JL, Dal Canto AJ, et al. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 1998; 188:577-588.
26. Huang S, Hendriks W, Althage A, et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259:1742-1745.
27. Harty JT, Bevan MJ. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity 1995; 3:109-117.
28. Zhang LH, Pan JP, Yao HP, et al. Intrasplenic transplantation of IL-18 gene-modified hepatocytes: An effective approach to reverse hepatic fibrosis in schistosomiasis through induction of dominant Th1 response. Gene Ther 2001; 8:1333-1342.
29. Zhang L, Mi J, Yu Y, et al. IFN-gamma gene therapy by intrasplenic hepatocyte transplantation: A novel strategy for reversing hepatic fibrosis in Schistosoma japonicum-infected mice. Parasite Immunol 2001; 23:11-17.
30. Pan J, Zhang M, Wang J, et al. Interferon-gamma is an autocrine mediator for dendritic cell maturation. Immunol Lett 2004; 94:141-151.
31. Bao Y, Zheng J, Han C, et al. Tyrosine kinase Btk is required for NK cell activation. J Biol Chem 2012; 287:23769-23778.
32. Bekeredjian-Ding I, Jego G. Toll-like receptors-sentries in the B-cell response. Immunology 2009; 128:311-323.
33. Gray D, Gray M, Barr T. Innate responses of B cells. Eur J Immunol 2007; 37: 3304-3310.
34. Dorshkind K, Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol 2007; 7:213-219.
35. Bao Y, Han Y, Chen Z, et al. IFN-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells. Eur J Immunol 2011; 41:657-668.
36. Hansell CA, Schiering C, Kinstrie R, et al. Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 2011; 117:5413-5424.
37. Harris DP, Haynes L, Sayles PC, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000; 1:475-482.
38. Barr TA, Brown S, Ryan G, et al. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 2007; 37:3040-3053.
39. Durali D, de Goër de Herve MG, Giron-Michel J, et al. In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood 2003; 102:4084-4089.
40. Yoshimoto T, Okamura H, Tagawa YI, et al. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 1997; 94:3948-3953.
41. Ganapamo F, Dennis VA, Philipp MT. CD19(+) cells produce IFN-gamma in mice infected with Borrelia burgdorferi. Eur J Immunol 2001; 31:3460-3468.
42. Kubota K, Kadoya Y. Innate IFN-producing cells in the spleen of mice early after Listeria monocytogenes infection: Importance of microenvironment of the cells involved in the production of innate IFN-. Front Immunol 2011; 2:26.
43. Williams MA, Schmidt RL, Lenz LL. Early events regulating immunity and pathogenesis during Listeria monocytogenes infection. Trends Immunol 2012; 33:488-495.
44. Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004; 4:812-823.
45. Singh A, Qin H, Fernandez I, et al. An injectable synthetic immune- priming center mediates efficient T-cell class switching and T-helper response against B cell lymphoma. J Control Release 2011; 155:184-192.
46. Elluru SR, Vani J, Delignat S, et al. Modulation of human dendritic cell maturation and function by natural IgG antibodies. Autoimmun Rev 2008; 7:487-490.
47. Cerutti A, Puga I, Cols M. Innate control of B cell responses. Trends Immunol 2011; 32:202-211.
48. Draing C, Sigel S, Deininger S, et al. Cytokine induction by Gram-positive bacteria. Immunobiology 2008; 213:285-296.
49. Ma F, Xu S, Liu X, et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-. Nat Immunol 2011; 12:861-869.
50. Harris DP, Goodrich S, Gerth AJ, et al. Regulation of IFNgamma production by B effector cells: Essential roles for Tbet and the IFN-gamma receptor. J Immunol 2005; 174:6781-6790.
51. Liu X, Zhan Z, Li D, et al. Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk. Nat Immunol 2011; 12:416-424.
52. Lauvau G, Vijh S, Kong P, et al. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 2001; 294:1735-1739.
53. Zhang T, Liu S, Yang P, et al. Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b/Src/beta-catenin pathway. Blood 2009; 114:4081-4088.
54. Celada A, Gray PW. Rinderknecht E. Evidence for a gammainterferon receptor that regulates macrophage tumoricidal ac tivity. J Exp Med 1984; 160:55-74.
55. Han C, Jin J, Xu S, et al. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 2010; 11:734-742.
56. Kanehisa M. Molecular network analysis of diseases and drugs in KEGG. Methods Mol Biol 2013; 939:263-275.